Patent · US Expired

Fibrin sponge

US6548729B1 · kind B1 · utility

42Cited by

5References

42Claims

0Family size

Assignees

Baxter Aktiengesellschaft · AT
Baxter International Inc. · US

Inventors

Thomas Seelich · Wien, AT
Edgar Scheel · Hagen, DE
Johann Odar · Östringen, DE
Yves A. Delmotte · Neufmaison, BE

Key dates

Filing date	May 26, 2000
Grant date	Apr 15, 2003
Priority date	—
Expiry date	May 26, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L31/046
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The invention relates to a fibrin sponge comprising a residual moisture content of at least 3%, preferably of 3 to 35%, in particular 10 to 20%, and preferably containing a blood clotting activator or proactivator, a method of preparing this fibrin sponge as well as a kit for wound gluing which comprises the fibrin sponge and a component containing a blood clotting factor. The sponge according to the present invention is suitable for hemostasis, tissue adhesion and aiding wound healing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.